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OBJECTIVE—Analysis of energy expenditure (EE) in mice is
essential to obesity research. Since EE varies with body mass,
comparisons between lean and obese mice are confounded
unless EE is normalized to account for body mass differences.
We 1) assessed the validity of ratio-based EE normalization
involving division of EE by either total body mass (TBM) or lean
body mass (LBM), 2) compared the independent contributions of
LBM and fat mass (FM) to EE, and 3) investigated whether leptin
contributes to the link between FM and EE.
RESEARCH DESIGN AND METHODS—We used regression
modeling of calorimetry and body composition data in 137 mice
to estimate the independent contributions of LBM and FM to EE.
Subcutaneous administration of leptin or vehicle to 28 obese
ob/ob mice and 32 fasting wild-type mice was used to determine
if FM affects EE via a leptin-dependent mechanism.
RESULTS—Division of EE by either TBM or LBM is confounded
by body mass variation. The contribution of FM to EE is compara-
ble to that of LBM in normal mice (expressed per gram of tissue)
but is absent in leptin-deﬁcient ob/ob mice. When leptin is adminis-
tered at physiological doses, the plasma leptin concentration sup-
plants FM as an independent determinant of EE in both ob/ob mice
and normal mice rendered leptin-deﬁcient by fasting.
CONCLUSIONS—The contribution of FM to EE is substantially
greater than predicted from the metabolic cost of adipose tissue
per se, and the mechanism underlying this effect is leptin
dependent. Regression-based approaches that account for varia-
tion in both FM and LBM are recommended for normalization of
EE in mice. Diabetes 59:1657–1666, 2010
T
he maintenance of stable body weight is
achieved through a process termed “energy ho-
meostasis” that matches energy intake to energy
expenditure (EE) over long time intervals (1).
Accordingly, when animals experience a sustained in-
crease of energy intake (e.g., during consumption of an
energy-rich highly palatable diet), an adaptive increase of
metabolic rate can help to limit the associated weight gain
(2). However, the ability to quantify adaptive changes of
EE is confounded in that larger animals tend to have a
higher metabolic rate than smaller ones. Therefore, to
reliably detect changes in EE that are not due simply to
differences in body size per se, EE must be normalized
to body mass using a method that eliminates this con-
founding effect. To date, most rodent studies of obesity
use ratio-based normalization methods whereby EE is
divided by either total body mass (TBM) or lean body mass
(LBM) (3–6). However, these two methods can give widely
divergent results when applied to the same data (3,4,6,7).
A recent Diabetes Perspectives article (7) cogently
reviewed the confounding effect of normalizing EE via
division by TBM in mice, particularly when groups being
compared differ in fat mass (FM). Accompanying this
caution was the recommendation that EE be normalized
via division by LBM instead (7) on grounds that FM
consumes much less energy than LBM. Despite its intuitive
appeal, dividing EE by LBM is theoretically problematic as
a means to remove the inﬂuence of body size variation
from group comparisons. The linear relationship between
EE and either TBM or LBM is typically characterized by a
positive y (EE) intercept term (8–13) due to heterogeneity
inherent in the EE of various tissues comprising LBM (14).
Consequently, dividing resting or average EE by either
TBM or LBM mathematically forces heavier individuals to
have a lower normalized EE than smaller ones (8–13), a
concept ﬁrst articulated 60 years ago (8). One approach
that has been forwarded to obviate this mathematical bias
is to use allometric scaling (15) wherein a TBM scaling
exponent b and scaling coefﬁcient a must be identiﬁed
based on the data (15,16) such that EE divided by TBM
b
assumes the constant expected value a. This approach,
however, is limited by interpretational and other difﬁcul-
ties (17), and the notion that a predetermined ﬁxed TBM
scaling exponent can be applied universally has been
challenged (16,18).
Normalizing EE in human studies is now accomplished
using multiple regression methods that adjust group com-
parisons of EE for differences in body mass so as to
eliminate the inﬂuence of body size variation per se from
evaluations of key independent variables such as ethnicity,
sex, genotype, or nutritional status (9,19–28). Although
multiple regression has been used in animal studies
(11,29–35), the relative importance of FM and LBM as
determinants of metabolic rate in mice remains an open
question. Indeed, both human and animal investigations
suggest that the energy cost of FM in vivo is greater than
expected on the basis of its intrinsic metabolic rate
(20,28,31,36). This possibility is consistent with evidence
that changes in FM can inﬂuence metabolic rate at least in
part through homeostatic adjustments of EE that promote
body weight stability (2,37–42). Testing this hypothesis,
however, requires the application of valid strategies for
normalizing EE to body size.
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mice that ratio-based normalization of EE is problematic,
even when LBM is used in lieu of TBM. Moreover, multiple
regression analysis indicates that variation in FM makes a
surprisingly large contribution to EE. These ﬁndings lead
us to support recommendations for the broad use of
regression-based approaches to normalizing EE in mice
that take both FM and LBM into account (9–12,19,43,44).
Based on the hypothesis that the effect of FM on EE
reﬂects adaptive responses involving the adipocyte hor-
mone leptin, we asked 1) whether the effect of FM on EE
is absent in ob/ob mice that lack a leptin signal, 2)i ft h e
plasma leptin level supplants FM as an independent deter-
minant of EE when leptin is administered to ob/ob mice at
physiological doses, and 3) whether in wild-type (WT)
mice rendered leptin-deﬁcient by fasting, the plasma leptin
level emerges as a determinant of EE when physiological
replacement is achieved by exogenous leptin administra-
tion. Our results conﬁrm each of these predictions and
therefore implicate circulating leptin in the mechanism
whereby FM variation affects EE.
RESEARCH DESIGN AND METHODS
Animal use and care. The mouse sample used in the regression analysis to
identify the independent roles of LBM and FM as determinants of EE (the
main regression analysis) was aggregated from four separate projects involv-
ing separate mouse cohorts evaluated over the 2-year period from 2006 to 2008
at the Mouse Metabolic Phenotyping Center (MMPC, funded by the National
Institutes of Health) located at the University of Washington. Per the policies
of this program, the nature of the speciﬁc mutations affecting mice used in
portions of this analysis (a total of four mutations affecting a subset of 71
mice) cannot be disclosed until the investigators who generated these mice
have independently published their ﬁndings. Studies examining the effect
leptin replacement has on EE used ob/ob mice and WT C57BL/6J mice
obtained from Jackson Laboratories (Jackson Laboratories, Bar Harbor, ME).
All animals were housed singly in a speciﬁc pathogen-free AAALAC-accredited
facility (25–26°C; 12:12-h light-dark cycle) with free access to food and water
unless otherwise indicated. All procedures were approved by the Institutional
Animal Care and Use Committee of the University of Washington.
Main regression analysis. Each of the four mouse cohorts was arbitrarily
assigned a project number. The total sample size was 137. All metabolic and body
composition evaluations were conducted by the same investigator (K.O.) at the
University of Washington MMPC facility. Additional inclusion criteria included
body composition analysis via high-precision magnetic resonance methodology
(described below) and being fully backcrossed onto the C57/BL6 background
(minimum of 10 generations) (to avoid confounding by differences in background
strain). Mice with monogenic obesity (e.g., ob/ob, db/db, A
y, etc.) were excluded
based on the hypothesis that such mutations disrupt the normal relationship
between body composition and metabolic rate. Mice were tested after periods of
ad libitum feeding of either standard mouse chow (#5015; PMI Nutrition Interna-
tional, Brentwood, MO; 21% of calories from fat) or a high-fat diet (HFD)
providing 42–60% of calories from fat depending on the project (P) as follows: P1:
Bio-Serv (Frenchtown, NJ) #S3282 (58% of calories from fat); P2: Harlan-Teklad
(Madison, WI) #TD88137 (42%); P3: Research Diets (New Brunswick, NJ)
#D12492 (60%); P4: Research Diets #D12451 (45%).
Regression modeling and statistical analysis. Regression modeling was
performed using R (www.r-project.org) and SPSS (v. 17; IBM, Chicago, IL)
using robust variance estimation. Signiﬁcance was established at P  0.05
(two-tailed). Correlations are reported as Pearson r values.
The 24-h average and minimum light cycle EE values, measures of average
and resting metabolic rate, respectively, were the dependent variables in the
main regression analysis. Minimum light cycle EE was the lowest EE recorded
in association with no activity, and all values were compared to the 5th
percentile value of EE to preclude the use of erroneous outlier values in the
analysis. The independent variables included LBM, FM, diet, activity, and sex
as well as the “project by genotype” (PG) interaction. The latter enabled us
to estimate the unique inﬂuence on EE due to the genotype (WT versus
mutant) within each of the four projects (see the supplemental online
appendix at http://diabetes.diabetesjournals.org/cgi/content/full/db09-1582/
DC1). Age was also examined but proved inconsequential after adjustment for
the other factors. We also conducted two sub-analyses restricted to each of
the two largest projects: project 1 (n  50) and project 2 (n  41).
Concern regarding the validity of normalizing EE via division by TBM or
LBM is based on evidence (8–13) that resting and average EE typically scale
as linear functions of TBM or LBM characterized by positive y-intercepts
[EE  b1 (TBM or LBM)  b0, where b1 is a positive slope parameter and b0
is a positive intercept term]. Consequently, ratio-normalized EE (RNEE)
calculated by dividing EE by either TBM or LBM is predicted to scale as a
rational function for which value decreases with increasing body size
[RNEE  EE/(TBM or LBM)  b1  b0/(TBM or LBM)] (8). Accordingly, we
used nonlinear regression (KaleidaGraph; Synergy Software, Reading, PA) to
ﬁt a rational function of this form to ratio-normalized EE outcomes to assess
the validity of ratio-based normalization methods.
Considerations relating to the use of allometric scaling to normalize EE
data are addressed in the online appendix.
Respiratory gas exchange analysis and EE quantiﬁcation. VO2 and VCO2
were quantiﬁed using an Oxymax System (CLAMS; Columbus Instruments,
Columbus, OH). After habituation to the respiratory chambers, mice were
tested over a continuous duration of 36 h, encompassing a minimum of two
dark cycles and one light cycle. The second light and dark cycles were
selected as the 24-h period of metabolic data analysis. Ambient temperature
during testing was 25.6  0.5°C. Measurements of respiratory gas exchange
were made at 27-min intervals, as were external air reference values to permit
baselining (10). VO2 and VCO2 were calculated as described by Lighton (10).
The respiratory exchange ratio (RER) was calculated as VCO2/VO2. EE data
are expressed in terms of calories per minute using the Lusk equation (45): EE
in cal/min  (3.815  1.232  RER)  VO2 in ml/min.
Body composition analysis. Body composition was evaluated by quantita-
tive nuclear magnetic resonance spectroscopy using an EchoMRI 3-in-1
Animal Tissue Composition Analyzer (ET #103) and EchoMRI software
(version 2004_1.54). Calibration standards were as follows: chicken breast for
LBM, canola oil at 37°C for FM, and tap water at 37°C for free body water.
LBM and FM were quantiﬁed based on the averages of triplicate measures in
each of the 137 tests performed. The coefﬁcients of variation for the triplicate
measures were 1.97% for FM and 0.61% for LBM.
Leptin replacement studies. The dependent variable in the leptin replace-
ment studies was the 24-h average EE encompassing one complete light and
dark cycle. Independent variables were LBM, FM, and plasma leptin levels.
Leptin replacement in ob/ob mice. Adult male ob/ob mice (10 weeks of
age) were individually housed and habituated to calorimeter cages before
study. After baseline body composition analysis, mice were placed in the
calorimeter just before dark cycle onset for 64 h with ad libitum access to
standard chow and water. Baseline (pre–leptin/vehicle infusion) EE was
based on average EE between 36 and 60 h. Animals were removed from the
calorimeter, separated into weight-matched groups, and subcutaneously im-
planted with an osmotic minipump (Alzet Model 1007D; DURECT Corpora-
tion, Cupertino, CA) containing either vehicle (sodium bicarbonate; pH 7.4) or
leptin at doses of 50, 100, or 200 ng/h (Dr. A.F. Parlow; National Hormone &
Peptide Program, CA) (n  7 per group), designed to achieve leptin levels in
the low-, medium-, and high-physiological range. A Lynch coil was attached to
each osmotic minipump to permit a 24-h period of saline vehicle infusion
before drug delivery. Animals were then returned to the calorimeter, just
before dark cycle onset, for an additional 64 h of monitoring. After a ﬁnal
body composition analysis, mice were killed, and blood was collected with
plasma removed for measurement of leptin levels by ELISA (Crystal Chem,
Chicago, IL).
Leptin replacement in fasted wild-type mice. Age- and weight-matched
male C57Bl/6J mice were implanted with an osmotic minipump containing
either vehicle or leptin as described above. Thirty hours later, animals were
placed in the calorimeter just before a dark cycle for 36 h with ad libitum
access to water only. The reported EE was the average EE across a 24-h
period between 12 and 36 h during the fasting studies. After calorimetry, body
composition was performed and blood was obtained for plasma leptin
measurements.
RESULTS
FM as an independent predictor of EE: subject char-
acteristics and variability of fat and lean mass. Sub-
ject characteristics stratiﬁed by diet are summarized in
Table 1. Within diet groups, variability in LBM was modest
(coefﬁcient of variation [CV] 12–20%) relative to FM (CV
53%), with the latter being the predominant source of
variability in TBM (CV 20–26%). As expected, percent
body fat was substantially increased in HFD versus the
standard chow groups (36.8  12.3 vs. 15.8  5.8% fat,
respectively).
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determine whether dividing EE by TBM or LBM can
effectively control for body size–related variation in EE,
we performed the correlation analyses shown in Fig. 1. EE
was linearly related to TBM (Fig. 1A and G) and LBM (Fig.
1B and H), and these linear relationships were character-
ized by positive y-intercepts, as expected (14). As a result
of the positive intercepts, ratios formed from dividing EE
by either TBM (Fig. 1D and J) or LBM (Fig. 1E and K) are
mathematically forced to decrease with increasing values
of body size. The mathematical basis for this effect is
described in RESEARCH DESIGN AND METHODS. The negative
slope of the relationships between normalized metabolic
rate and either TBM or LBM demonstrate that ratio-based
methods do not remove the effect of body size variation
from metabolic rate. Consequently, within diet groups,
heavier mice in Fig. 1 have a lower average ratio-normal-
ized EE than do lighter animals, irrespective of whether or
not the heavier mice actually have lower standardized EE
values when EE is standardized to mass in a way that
demonstrably removes the effect of mass variation from
the group comparisons.
In HFD-fed mice, non-normalized EE increased more
steeply with increases of LBM than in chow-fed mice (Fig. 1B
and H; comparisons of slope coefﬁcients within diet groups
are signiﬁcant at P  0.00001), and ratio-normalized EE
values for the HFD group were displaced upward in compar-
ison to those for chow-fed mice (Fig. 1D, E, J, and K). Thus,
the average increase of EE per gram increase of LBM in
HFD-fed mice exceeds that observed in chow-fed mice,
implying that greater FM (or consuming an HFD per se)
increases the metabolic rate of LBM. That diet composition
inﬂuences the relationship between EE and LBM confounds
LBM ratio–normalized EE values and suggests that variation
in FM should also be taken into account.
Surprisingly, we found that FM was more strongly
correlated with both average and minimum EE (Fig. 1C
and I; overall r  0.87 in both panels; P  0.0001) than was
LBM (Fig. 1B and H; overall r  0.63 and r  0.54,
respectively; P  0.0001). Notably, the overall relationship
between FM and LBM was positive and highly signiﬁcant
(r  0.59; P  0.00001). As shown in Fig. 1F and L, when
the components of EE that were uncorrelated with LBM
(i.e., the EE residuals) were regressed on the components
of FM that were uncorrelated with LBM (the FM residu-
als), the relationship between EE and FM remained strong
and highly signiﬁcant (r  0.8; P  0.00001), suggesting
that FM and LBM each contribute to EE independently.
Reinforcing this assessment, Fig. 2 shows the relationship
between the EE residuals and the FM residuals depicted in
Fig. 1F and L stratiﬁed by project and genotype. The
residual EE versus residual FM associations in Fig. 2 are
positive and signiﬁcant in all subgroups except for those
involving project 3, which entailed small sample sizes (n 
8 chow, n  8 HFD). To further investigate the indepen-
dent roles of LBM and FM as determinants of EE, we next
performed multiple regression analysis.
Regression models for predicting EE. In a multiple
regression model predicting average EE as a function of
LBM, FM, sex, diet, activity, and membership in each
subgroup deﬁned by project and genotype (Fig. 2), both
LBM and FM were highly signiﬁcant independent predictor
variables (0.269  0.039 and 0.144  0.023 cal/g tissue
mass/min, respectively; P  0.00001 for both). Multiple
regression modeling of minimum EE as a function of all
these independent variables (except activity) revealed that
both LBM and FM were highly signiﬁcant independent
predictor variables with similar magnitudes (0.144  0.030
and 0.143  0.021 cal/g tissue mass/min, respectively; P 
0.00001). The full models are shown in the online appen-
dix. Note that the predicted change of 24-h average EE for
each 1-g change of FM represents 53% of the estimated per
gram impact of LBM, while the contributions of FM and
LBM to minimum EE were essentially equal. Note also that
the inﬂuence of FM is similar regardless of whether 24-h
average or minimum EE is used in the regression models,
whereas the LBM term is larger for 24-h average than for
minimum EE. Thus, after controlling for the independent
effects on EE of LBM, diet, sex, activity, and subgroup
membership, FM remains a highly signiﬁcant and quanti-
tatively important determinant of murine EE. Importantly,
the overall impact of FM varies in proportion to body fat
content such that it would seem essential to include this
compartment when EE comparisons are made between
lean and obese mice to detect differences in EE that are
not confounded by body size and composition.
Several of these regression-based ﬁndings are consistent
with what is known about factors that inﬂuence EE. For
example, the ﬁnding that the per gram values associated
with LBM (but not FM) were higher for 24-h average than
for minimum EE is consistent with the greater metabolic
activity in LBM tissues (e.g., skeletal, cardiac, and respi-
ratory muscles) needed to power activities such as loco-
motion and rearing that are reﬂected in average EE. Diet
and sex were also signiﬁcant independent predictors of EE
(for coefﬁcient estimates, see the online appendix).
The conclusion that FM and LBM are independent
determinants of murine EE should not imply that the
identiﬁed FM and LBM coefﬁcients will generalize to any
particular experimental setting. To the contrary, our re-
sults suggest that the relative impact of FM versus LBM on
EE can vary substantially depending on common variables
such as the genotype and diet intervention being studied.
This point is illustrated by comparing project 1 (n  50)
and project 2 (n  41) sub-analyses, which included LBM,
FM, genotype, sex, and diet to predict average 24-h EE.
For project 1, after adjustment for the other independent
variables, the coefﬁcient estimates were similar for FM
and LBM (0.242  0.046 cal/g/min [P  0.00001] versus
0.221  0.064 cal/g/min [P  0.001]). By contrast, in project
2, the coefﬁcient for FM was 0.091  0.037 cal/g/min (P 
0.01), whereas for LBM it was 0.397  0.118 cal/g/min (P 
0.001). Because the coefﬁcients for FM and LBM can vary
TABLE 1
Characteristics of the mice used to estimate contributions of FM
and LBM to EE
Chow diet HFD
n 89 48
Body mass (g) 21.51  4.22 36.90  9.47
LBM (g) 17.10  3.33 21.16  2.50
FM (g) 3.48  1.85 14.60  7.79
% Body fat 15.83  5.78 36.81  12.33
Age (weeks) 7.80  3.77 16.17  2.40
Activity (counts/min) 22.31  8.81 12.06  6.58
24-h mean RER 0.928  0.030 0.833  0.050
Minimum light cycle RER 0.772  0.058 0.752  0.037
24-h mean EE (cal/min) 6.64  0.76 10.27  2.08
Minimum light cycle EE
(cal/min) 4.14  0.62 7.44  1.76
Data are means  SD. RER, respiratory exchange ratio.
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diabetes.diabetesjournals.org DIABETES, VOL. 59, JULY 2010 1659FIG. 1. Limitations inherent in the use of traditional ratio methods for normalizing EE to TBM or LBM in mice fed either standard food (E, n 
89) or a HFD (F, n  48). Both average (A and B) and minimum (G and H) EE vary as linear functions of TBM or LBM. Because the regression
lines characterizing these relationships have positive intercepts, normalizing EE as a simple ratio of total or lean body mass (EE/TBM or EE/LBM)
yield negative nonlinear associations between the normalized values and body mass compartments (D, E, J, and K). Consequently, the normalized
EE values decrease with increasing body mass irrespective of whether or not the heavier mice actually have lower standardized EE values when
EE is standardized to mass in a way that demonstrably controls for the inﬂuence of mass variation. (See RESEARCH DESIGN AND METHODS for the
mathematical premise underlying this analysis). C and I depict the positive association between EE and FM across studies, while F and L
demonstrate that the relationship between EE and FM remains highly signiﬁcant even after accounting for the contribution of LBM to each trait,
indicating that FM predicts EE independently of LBM in these mice. Interpretation: Within diet groups, commonly used ratio normalization
methods spuriously assign a more efﬁcient (lower) metabolic rate phenotype to larger animals. In addition, between diet groups, these
ratio-based normalization methods favor assignment of an elevated metabolic rate phenotype to the HFD-fed heavier mice (and this bias is
magniﬁed when LBM is used in the ratio) because the increase of EE is disproportionate to the increase of LBM, as would be predicted if FM
exerts an independent positive effect on EE.
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1660 DIABETES, VOL. 59, JULY 2010 diabetes.diabetesjournals.orgFIG. 2. Relationship between EE and FM residuals (the components of EE and FM that are not explained by LBM) within eight subgroups
deﬁned by project number and genotype. E, Chow-fed mice; f, HFD-fed mice. The top two rows show the relationship between average EE
and FM residuals depicted in Fig. 1F stratiﬁed by project and genotype, and the bottom two rows do likewise for the minimum EE and FM
residuals depicted in Fig. 1L. The LBM-adjusted EE versus LBM-adjusted FM associations are positive and signiﬁcant in all subgroups
except for those involving project 3, which entailed small sample sizes (n  8 chow, n  8 HFD). Multiple regression models for EE as a
function of LBM, FM, sex, diet, activity, and membership in each subgroup deﬁned by project and genotype revealed that FM is a
quantitatively important and highly signiﬁcant determinant of murine EE (see text). Interpretation: FM is strongly associated with EE,
even after controlling for the relationship between each of these traits and LBM.
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a priori assumptions about the relative importance of FM
versus LBM as predictors of EE are difﬁcult to justify. By
comparison, regression-based normalization provides un-
biased estimates of the roles of FM and LBM as determi-
nants of EE based on the dataset being analyzed and hence
averts the need for such a priori assumptions. Unbiased
analyses of the impact of FM and LBM on EE are essential
to efforts both to identify the contribution of genetic or
other factors in EE phenotypes and to clarify the molec-
ular mechanisms involved.
Leptin replacement in ob/ob mice. To investigate
whether a leptin signal is required for variation in FM to
affect EE, we performed multiple regression analysis of
data obtained from 11-week-old leptin-deﬁcient ob/ob
mice at baseline and again during continuous subcutane-
ous infusion of either saline or leptin at a dose designed to
achieve plasma leptin levels in the physiological range.
Subject characteristics and bivariate associations.
For these studies, EE was expressed as the average 24-h
EE. Figure 3 illustrates key bivariate relationships involv-
ing EE, LBM, and FM and the consequences of leptin
replacement.
Multiple regression models. Table 2 shows coefﬁcient
estimates obtained in a multiple regression model for 24-h
average EE in ob/ob mice in leptin-deﬁcient and leptin-
replaced states. In addition, to further investigate whether
leptin administration affected the metabolic energy cost of
LBM, we also used a repeated-measures model in which
the LBM by state and FM by state interactions were
evaluated together with the main effects of the tissue
compartments. The LBM by state interaction was signiﬁ-
cant (P  0.002), whereas the FM by state interaction was
not (P  0.37). The resultant coefﬁcient for LBM in the
leptin-replaced state (0.663  0.206 cal/g/min) signiﬁcantly
exceeded (P  0.002) by 1.8-fold that obtained for the
leptin-deﬁcient state (0.374  0.273 cal/g/min). Thus, phys-
iological leptin replacement in ob/ob mice increases the
metabolic rate in a concentration-related fashion, and this
effect involves an increase in metabolic energy expendi-
ture occurring within LBM.
Effect of physiological leptin replacement in fasted
wild-type mice. As an additional test of whether leptin
contributes to the effect of variation in FM on EE, we
performed multiple regression analysis of body composition
and metabolic data obtained from WT mice rendered leptin-
deﬁcient by fasting. During a 36-h fast, eight mice received
continuous subcutaneous infusion of saline and remained
leptin-deﬁcient, whereas another 24 animals received subcu-
taneous leptin at doses designed to maintain physiological
plasma leptin levels (i.e., designed to block fasting-induced
reduction of the plasma leptin level).
Subject characteristics and bivariate associations.
EE was evaluated as the 24-h average EE recorded during
the ﬁnal 24 h of a 36-h fast. Table 3 summarizes morpho-
logical and metabolic variables, whereas Fig. 4 shows
scatterplots of 24-h average EE as functions of body mass
compartments and leptin levels in fasted mice receiving
either saline or leptin. Note the signiﬁcant positive asso-
ciation between plasma leptin levels and EE (Fig. 4B).
Multiple regression model. Multiple regression analysis
(Table 4) showed that whereas plasma leptin levels were
positively and signiﬁcantly associated with EE after ad-
justment for FM and LBM, neither LBM nor FM were
identiﬁed as signiﬁcant predictors of EE. When the effect
of fasting to lower plasma leptin levels is prevented by
exogenous leptin infusion, therefore, the effect of leptin on
metabolic rate exceeds that of either FM or LBM.
DISCUSSION
Although the concept that EE must be adjusted to control
for differences in body size is widely accepted
(8,9,11,13,19–35), the optimal method for this normaliza-
tion in mice remains to be established and is a focus of
intense current interest (7). Here we addressed whether it
matters how this normalization is accomplished and
whether a more optimal normalization strategy can help to
clarify the link between body composition and the control
of EE. We demonstrated that normalizing metabolic rate
by simply dividing EE by either TBM or by LBM does not
effectively control for the inﬂuence of mass variation.
Indeed, we conﬁrm previous evidence in humans
(8,9,13,43) that these ratio-based methods systematically
introduce error into the relationship between EE and body
mass. By comparison, regression-based methods analo-
gous to those that are well established in human obesity
research (9,19–28) provide valid control for the inﬂuence
of body size variation in comparisons involving EE. Com-
bined with our ﬁndings that FM is an unexpectedly impor-
tant determinant of metabolic rate in mice and that the
relative importance of FM versus LBM as a determinant of
EE can vary substantially across different mouse cohorts
(which challenges normalization strategies based on a
priori assumptions about the contributions made by these
body mass compartments), these observations support the
use of regression-based rather than ratio-based ap-
proaches when analyzing EE in this species. We also
report that the plasma leptin level (but not the level of FM)
emerges as a key determinant of metabolic rate when
leptin is administered to ob/ob mice at doses that achieve
physiological plasma levels, implying a role for leptin in
the link between variation in FM and metabolic rate.
The conclusion that FM is a quantitatively important
predictor of murine metabolic rate is supported by multi-
ple regression analyses using either of two measures of EE
(mean daily or 24-h minimum values) and by showing that
FM is associated with EE independently of LBM in normal
lean mice as well as in animals with obesity induced by HF
feeding. Although one might expect that FM would incur
an inconsequential metabolic energy cost because it pre-
dominantly consists of metabolically inert triglyceride,
this prediction is inconsistent both with our current re-
sults and with previous studies (20,28,31,36,40–42).
Rather than reﬂecting variation in the metabolic activity of
adipose tissue per se, we favor the hypothesis that the
demonstrated link between FM and EE involves compen-
satory responses involved in energy homeostasis triggered
by changes of body adiposity (2,37–42). Indeed, obesity
induced by consumption of an HFD occurs despite an
adaptive increase of metabolic rate that depends on the
sympathetic nervous system and serves to limit weight
gain (46,47). In rodents, adaptive thermogenesis involves
activation of brown adipose tissue, which is specialized to
generate heat in response to sympathetic nervous system
stimulation, as occurs both during the consumption of a
meal and after the switch to a highly palatable energy-rich
diet (46–48). Similarly, the efﬁciency of skeletal muscle
work during physical activity is also modulated in re-
sponse to changes of energy balance and storage (49,50).
Each of these factors could potentially contribute to the
mechanism whereby changes of FM affect EE.
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FIG. 3. Bivariate analyses indicate that caloric EE is positively related to LBM and to FM in ob/ob mice. Bivariate associations of average 24-h
EE, LBM, FM, and plasma leptin levels in 28 ob/ob mice that were studied ﬁrst at baseline and then again during continuous subcutaneous infusion
of either saline (n  7) or a dose of leptin intended to achieve physiological replacement (n  21) (range of plasma leptin achieved is shown in
D–F). A: EE was positively correlated with LBM in both the absence and presence of leptin administration, although the slope of this relationship
was steeper in the latter setting, consistent with a leptin-mediated increase of metabolic cost per unit LBM. B: Highly signiﬁcant co-variation
between LBM and FM occurred in both the presence and absence of leptin, which confounds the analysis of relationships between EE and tissue
compartments and hence illustrates the need for proper statistical control. C: EE was positively associated with FM before leptin replacement
(but the effect was not signiﬁcant after statistical adjustment; Table 2). D: EE varied directly with plasma leptin levels, but this association did
not reach signiﬁcance (this association became highly signiﬁcant when multiple regression analysis was used to account for variation in tissue
compartment masses; Table 2). E: As expected, leptin treatment was negatively related to the change from the baseline study in FM such that
higher leptin concentrations were associated with greater FM loss. F: Although mean LBM increased among ob/ob mice receiving subcutaneous
leptin, higher plasma leptin levels were associated with a tendency to limit LBM gain. Interpretation: Basic bivariate analyses indicate that the
slope of EE on LBM was higher in animals receiving leptin, consistent with an effect of leptin to augment energy expenditure in this tissue
(conﬁrmed in Table 2). EE was positively related to plasma leptin levels, consistent with an effect of leptin to augment metabolic rate (conﬁrmed
in Table 2). S.C., subcutaneous.
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and contributes to sympathetic nervous system–mediated
adaptive changes of both brown adipose tissue thermo-
genesis and skeletal muscle work efﬁciency (50). Leptin
mediates these effects by binding to and activating leptin
receptors in hypothalamic arcuate (51,52), ventromedial
(51,52), and dorsomedial (53) nuclei and in other brain
areas that integrate afferent signals pertinent to energy
balance (51). Thus, the elevated EE of fatter mice could
result, at least in part, from higher circulating leptin levels.
To test this hypothesis, we investigated whether leptin is
required for the effect of FM variation on EE.
In leptin-deﬁcient ob/ob mice, FM was not a signiﬁcant
independent determinant of EE, in contrast to what was
observed in the main regression analysis. While our mod-
est ob/ob sample size precludes ruling out a role of FM as
a determinant of EE in these mice, the data do suggest an
obligate role for leptin in the link between FM variation
and EE. In support of this hypothesis, we found that
when leptin is administered to ob/ob mice at doses that
achieve physiological replacement, the plasma leptin
level emerges as a robust independent predictor of EE,
even after adjusting for relevant covariates. Our multiple
regression models further suggest that this leptin effect
involves a marked increase in the metabolic energy cost of
LBM, consistent with previous studies (6,50).
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FIG. 4. Leptin replacement in the physiological range determines caloric
EE in fasting mice. A: Scatterplots of average EE values recorded during
the last 24-h period of a 36-h fast versus body mass compartments in
wild-type mice receiving continuous subcutaneous infusion of either
saline (n  8) or a physiological dose of leptin (n  24). B: Association of
average EE values with leptin concentrations in plasma obtained from the
same mice. Interpretation: Bivariate analyses indicates that EE in fasted
WT mice receiving leptin replacement in the physiological range is more
determined by the plasma leptin level than by LBM or FM (conﬁrmed in
Table 4).
TABLE 2
Multiple regression models for 24-h average EE (cal/min) in ob/ob
mice (n  28) evaluated in the leptin-deﬁcient state and subse-
quently evaluated again in the leptin-replaced state
Model for leptin-deﬁcient state
Independent variable Coefﬁcient*  SE P
Intercept 1.989  2.859 0.49
Lean body mass (g) 0.212  0.281 0.46
Fat mass (g) 0.120  0.106 0.27
Model for leptin-replaced state
Intercept 4.229  4.499 0.36
Leptin (ng/ml) 0.115  0.042 0.01
Lean body mass (g) 0.912  0.373 0.02
Fat mass (g) 0.086  0.122 0.49
*Estimated change in mean EE per unit change in the independent
variable. Separate models were ﬁt within each state. Interpretation:
Plasma leptin level and LBM are signiﬁcant independent determi-
nants of EE in ob/ob mice receiving short-term leptin replacement in
the physiological range. In addition to being signiﬁcant in the
leptin-replaced state, the estimated EE cost per gram increase in
LBM is over fourfold larger than it was in the leptin-deﬁcient state.
By comparison, the contribution of FM to EE in ob/ob mice did not
achieve signiﬁcance in either the presence or absence of leptin
administration.
TABLE 3
Morphological and metabolic variable summaries by treatment category in 10-week-old fasted wild-type mice that received
continuous subcutaneous infusion of either vehicle or leptin at a physiological dose
Group
Saline All leptin* Highest leptin†
n  8 n  24 n  8 P§ P
Body mass (g) 19.3  1.0 19.4  0.8 19.4  0.6 0.81 0.77
LBM (g) 16.0  0.8 16.2  0.7 16.3  0.5 0.47 0.32
FM (g) 1.6  0.4 1.5  0.4 1.4  0.3 0.78 0.29
% Body fat 8.0  1.4 7.7  1.9 6.9  1.6 0.67 0.17
Leptin (ng/ml) 0.3  0.3 7.1  4.5 11.9  3.2 0.0002 0.00001
Activity (counts/min) 55.4  14.7 44.2  16.2 40.4  9.7 0.09 0.03
RER 0.73  0.005 0.73  0.007 0.73  0.005 0.62 1.0
24-h mean EE (cal/min) 6.43  0.47 7.14  0.53 7.37  0.23 0.002 0.0002
Data are means  SD. n  32. *Group includes animals receiving 50, 100, and 200 ng leptin/h. †Group includes animals receiving only 200
ng leptin/h. §Signiﬁcance of comparison between saline and all leptin-treated mice. Signiﬁcance of comparison between saline and mice
receiving 200 ng leptin/h.
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levels were positively associated with EE in leptin-treated
ob/ob mice, despite an attendant loss of FM, contrasts
sharply with the positive association between FM and EE
in normal mice that have not received exogenous leptin.
This ﬁnding supports the hypothesis that variation in FM
affects EE via changes in leptin level, and hence that leptin
plays a more direct role to determine EE than FM per se.
Pertinent to these ﬁndings is the well-documented effect of
leptin to increase sympathetic outﬂow to brown adipose
tissue (54). The ﬁnding of reduced FM in leptin-treated
ob/ob mice also supports the hypothesis that the leptin-
stimulated increase of EE in these animals was fueled in
part via a marked increase of lipid oxidation, consistent
with previous ﬁndings (6) and the ﬁnding that RER was
negatively associated with leptin levels in leptin-treated
ob/ob mice (r  0.62; P  0.0004). In considering these
observations, it is worth noting that loss of body fat in
most other situations (e.g., during weight loss during
caloric restriction) is characterized by a fall in EE that
conserves fuel stores.
To determine if leptin can supplant FM as a determinant
of EE in a genetically normal animal model, we performed
an analogous physiological leptin replacement study in WT
mice rendered leptin deﬁcient by fasting. Our ﬁndings
suggest that the effect of fasting to lower EE may depend
on a low leptin level, since fasting markedly reduces both
plasma leptin levels and EE and since EE increases in
proportion to the plasma leptin concentration when leptin
is administered to fasted mice. As in ob/ob mice, we found
that physiological variation in the plasma leptin level was
a highly signiﬁcant positive predictor of EE in this setting,
despite the fact that FM was reduced in leptin-treated
animals. These observations support a model in which the
potent effect of fasting to reduce EE is mediated, at least
in part, via reduced leptin levels.
The notion that increased EE in heavier mice depends
on hyperleptinemia seems at odds with the concept of
obesity-associated leptin resistance, typically deﬁned as a
reduced ability of exogenous leptin either to suppress food
intake (55) or to activate signal transduction in key
hypothalamic areas such as the arcuate nucleus (54,56,57).
Indeed, this resistance is implicated in both the pathogen-
esis of obesity and in the mechanism underlying hyperlep-
tinemia in obese animals (1). Yet leptin exerts wide-
ranging physiological effects via widely distributed
neuronal populations (57) that appear to be differentially
sensitive to obesity-induced leptin resistance. Thus, ac-
quired resistance to the food intake suppressing action of
leptin can coexist with the preservation of continued
sensitivity to other leptin effects, including stimulation of
renal and cardiovascular sympathetic nervous system out-
ﬂow (56,58). Accordingly, obese hyperleptinemic animals
that are relatively resistant to leptin’s anorexic effect may
nonetheless experience a heightened leptin stimulation of
EE. Evaluating the mechanisms underlying and extent of
resistance to leptin-stimulated increases in EE in obese
animals is fertile ground for future study.
In summary, our analysis supports the recommendation
that both FM and LBM be taken into account when
comparing EE among groups of mice with differing body
mass. Moreover, simple normalization methods such as
dividing EE by body weight or LBM do not adequately
account for the effect of variation in body size, whereas
multiple regression-based approaches achieve this goal
effectively provided that sample sizes are appropriate (see
the online appendix). Lastly, we conclude that FM contrib-
utes to EE in mice via mechanisms that are related less to
the metabolic cost of adipose tissue per se than to
leptin-dependent adaptive responses involved in the ho-
meostasis of body energy stores.
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